Clinigen Group Share Price (CLIN)

0.00 0.00 (0.00%) delayed: 4:16AM GMT
Bid price 920.50 Open price 0.00
Ask price 923.00 Prev close 920.50
High price 0.00 Spread 0.00%
Low price 0.00 Volume 0

Register now for FREE live Clinigen Group share prices, Clinigen Group stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Clinigen Group Level 2 Data, indepth research tools and investor commentary for Clinigen Group (CLIN) and other London Stock Exchange equities.

Clinigen Group Share Price Chart

Advanced Charts >>

Register now for FREE Clinigen Group share price charts

Clinigen Group Share Price Information

Name Clinigen Group Epic CLIN
Sector Pharmaceuticals & Biotechnology ISIN GB00B89J2419
Activites Clinigen Group plc is a global pharmaceutical and services company with a unique combination of businesses focused on providing access to medicines. Its mission is to deliver the right medicine to the right patient at the right time through three areas of global medicine supply; clinical trial, unlicensed and licensed medicines. Index n/a

Clinigen Group Key Numbers

Latest Share Price (p) 0.00 Net Gearing (%) 42.17
Market Capitalisation (£m) 1,215.74 Gross Gearing (%) 47.61
Shares in issue (m) 132.43 Debt Ratio 36.83
P/E Ratio 40.09 Debt-to-Equity Ratio 0.64
Total dividends per share (p) 5.60 Assets / Equity Ratio 1.91
Dividend Yield (%) 0.00 Price to book value 3.48
Dividend cover (x) 4.09 ROCE (%) 6.49
Earning per share (p) 22.90 EPS Growth (%) 593.94
52 week high / low 1,067.00 / 716.00 DPS Growth (%) 12.00

Clinigen Group Director Deals

Dec.Date Type Director Pos No. of Shares
01/10/2018 PLAC Shaun Chilton CEO 7,101
01/10/2018 PLAC Anne Hyland NED 4,142
24/11/2017 SELL Chris Rigg RES 4,955
16/10/2017 SELL Shaun Chilton CEO 100,000
03/10/2017 SELL John Bacon RES 250,000

More Clinigen Group Director Deals >>

Clinigen Group Company News

08:10 20/02/2019

Broker Forecast - Peel Hunt issues a broker note on Clinigen Group

Peel Hunt today reaffirms its buy investment rating on Clinigen Group (LON:CLIN) and raised its price target to 1390p (from 1300p). Story provided by Broker Forecasts data provided by

07:00 13/02/2019

Clinigen to acquire US rights to Proleukin

RNS Number : 8211P Clinigen Group plc 13 February 2019   13 February 2019   Clinigen to acquire US rights to Proleukin®   Clinigen Group plc (AIM: CLIN, 'Clinigen' or the 'Group'), the global pharmaceutical and services company, has signed an agreement with...

07:00 12/02/2019

Notification of half year results date

RNS Number : 6853P Clinigen Group plc 12 February 2019   12 February 2019   Notification of half year results date     Clinigen Group plc ('Clinigen' or the 'Group', AIM: CLIN), the global pharmaceutical and services company, will announce its half year...

More Clinigen Group Company News >>

Register now for FREE Clinigen Group company news

Clinigen Group Share Price Discussions

1 months ago

Clinigen Group plc (CLIN)

Dealings in Clinigen shares are expected to commence on AIM at 8.00am on Tuesday 25 September 2012, under the ticker symbol CLIN Clinigen is a rapidly-growing specialty pharmaceutical and services company, with one clear aim: to deliver the right drug to the right patient at the right...

Register now for FREE Clinigen Group share price discussions